Netflix exec sues over $1.1M job loss after disclosing medical ketamine therapy

Kevin Baillie lost his $1.1M annual position and was denied severance pay after disclosing his mental health treatment.
Netflix tells employees to be open. Then it fired him for being honest.
Baillie disclosed medical ketamine therapy during a retreat designed to encourage vulnerability, then was terminated months later.
Mark

Why would Netflix investigate a medical disclosure as if it were recreational drug use?

Mimi

The investigator seems to have either misunderstood what ketamine therapy is, or chose to treat it suspiciously. Baillie had been transparent about the medical context—a clinic, a prescription, a legitimate treatment for depression. But the investigation reframed it as potential misconduct.

Mark

Did his performance actually warrant termination?

Mimi

Not according to his own record. His previous review had addressed his swearing but didn't demand he stop. The alcohol incident was him doing a party trick a colleague asked him to perform. These weren't new problems; they were part of who he was, and Netflix seemed to accept that until the ketamine disclosure.

Mark

But Netflix's culture memo says they want vulnerability. Isn't that what he gave them?

Mimi

Exactly. That's the contradiction at the heart of this. Netflix tells employees to be open, to share personal experiences, to admit struggles. Baillie did that. Then the company treated his honesty as a liability and used it against him.

Mark

What does ketamine therapy actually treat?

Mimi

Depression, particularly treatment-resistant depression. The FDA approved a ketamine nasal spray for exactly this purpose. It's not a party drug in this context—it's medicine. Baillie took it under medical supervision after his mother's death. That's a legitimate health decision.

Mark

What's at stake in this lawsuit beyond Baillie's money?

Mimi

It's about whether employees can actually trust workplace vulnerability initiatives. If disclosing mental health treatment becomes grounds for termination, no one will disclose anything. Companies will get the silence they claim to want to eliminate, but through fear instead of culture change.

  • A man shared something true and private during a corporate vulnerability exercise — and lost a $1.1 million career for it.
  • Netflix's own investigation reframed a legal, doctor-prescribed medical treatment as potential recreational drug use, distorting the nature of what Baillie had disclosed.
  • The company that publicly champions candor, feedback, and openness now faces a lawsuit alleging it punished an employee for practicing exactly those values.
  • Minor behavioral notes — profanity, a party trick with a Guinness — were folded into the case against him, raising questions about pretextual reasoning.
  • Baillie is seeking a jury trial, lost wages, and punitive damages, while Netflix has yet to publicly respond, leaving the gap between stated values and alleged actions unaddressed.

In the hills of Northern California, a man did what his employer asked of him — he was vulnerable, honest, and open about his struggles. Kevin Baillie, a senior Netflix executive, disclosed his medically supervised ketamine therapy for depression during a company retreat designed for exactly that kind of candor, only to find himself investigated and terminated three months later. The case now asks a question that extends far beyond one man's career: when institutions invite human beings to bring their whole selves to work, do they bear a responsibility to honor what is offered?

Kevin Baillie stood up at a Netflix retreat in Northern California and told his colleagues something personal: he had undergone ketamine therapy for depression after his mother died in 2022. The treatment was legal, medically supervised, and administered at a licensed clinic in Santa Barbara. He shared it during an exercise explicitly designed to encourage openness.

Three months later, Netflix fired him. Baillie had served as vice president and head of creative at the company's Eyeline Studios visual effects division, earning roughly $1.1 million annually. The company also withheld what could have amounted to a year of severance pay.

His lawsuit alleges that during a March investigation, Netflix's inquiry framed his therapy as potential recreational drug use — a significant distortion. Ketamine is a Schedule III substance, but it carries FDA approval as an anesthetic and, in a derived nasal spray form, for treatment-resistant depression. What Baillie had done was medically appropriate and entirely legal.

The investigation also swept in smaller matters: his use of profanity and a moment at the retreat when a colleague asked him to demonstrate a family trick involving drinking a Guinness while standing on his head. His prior performance review had noted his language but stopped well short of ordering him to stop swearing altogether.

The deeper tension in the case lies in Netflix's own public culture memo, which celebrates vulnerability, candor, and openness as core values. The company instructs managers to evaluate employees on their full record and encourages workers to admit mistakes and share personal learnings widely. Baillie's attorney argues that his ketamine disclosure factored directly into his termination — meaning the company may have used its own vulnerability framework as the mechanism for his undoing.

Before Netflix, Baillie had worked on visual effects for the Pirates of the Caribbean and Harry Potter franchises. He is now seeking a jury trial, lost wages, and punitive damages. The case has not yet received a public response from Netflix, and it remains an open question whether corporate cultures that invite honesty are prepared — or willing — to protect it.

Kevin Baillie stood up during a vulnerability exercise at a Netflix retreat in Northern California in January and told his colleagues something true about himself: he had undergone ketamine therapy for depression. The drug had been prescribed and administered by doctors at a Santa Barbara clinic in 2022, after his mother died. It was legal, medically supervised, and it had helped him. He shared this during an exercise explicitly designed to encourage employees to be open about their personal experiences.

Three months later, in April, Netflix fired him. Baillie, who had served as vice president and head of creative at the company's Eyeline Studios visual effects division, earned roughly $1.1 million a year. The company also withheld what could have been as much as a year of severance pay. Now he is suing, claiming that his disclosure of medical ketamine treatment became the reason he lost his job.

The lawsuit, filed in court and reported by The New York Post, alleges that Netflix's investigation into Baillie's conduct mischaracterized his therapy. When an investigator questioned him on March 18, according to the complaint, the ketamine treatment was presented as potential recreational drug use—a framing that distorted what Baillie had disclosed. Ketamine is a Schedule III controlled substance, but it is federally approved as an anesthetic and is prescribed off-label for depression. The FDA has also approved Spravato, a ketamine-derived nasal spray, specifically for treatment-resistant depression under medical supervision. What Baillie had done was legal and medically appropriate.

The investigation also examined other matters: his use of profanity and his consumption of alcohol. During the same retreat, Baillie had mentioned that his former father-in-law had taught him to drink a Guinness while standing on his head. A colleague asked him to demonstrate. He did. His previous performance review had addressed his language but had not directed him to stop swearing entirely. "Drop one or two less f-bombs but don't stop entirely," the review said, according to the complaint.

What makes this case peculiar is Netflix's own stated values. The company's public culture memo promotes vulnerability and candor. It describes the organization as a professional sports team rather than a family. Managers are instructed to apply a "keeper test" when deciding whether to retain employees—asking themselves whether they would fight to keep this person if they wanted to leave, or whether they would hire them again knowing everything they know now. "If the answer is no, we believe it's fairer to everyone to part ways quickly," the memo states. The company also says that workers should receive regular feedback and be evaluated on their entire record. "You willingly receive and give feedback; you are open about what's working and what needs to improve; you admit mistakes openly and share learnings widely," the site declares.

Baillie's attorney stated in the lawsuit that "the ketamine therapy issue has factored into the termination." He is seeking a jury trial, lost wages, compensatory and punitive damages, and damages for emotional distress. Before joining Netflix, Baillie had worked on visual effects for the "Pirates of the Caribbean" and "Harry Potter" franchises. As of the time this lawsuit was reported, Netflix had not publicly responded to his allegations. The case now sits in the gap between what a company says it values and what it appears to have done when an employee took those values at face value.

The ketamine therapy issue has factored into the termination
— Baillie's attorney, in the lawsuit
You willingly receive and give feedback; you are open about what's working and what needs to improve; you admit mistakes openly and share learnings widely
— Netflix's public culture memo
Envie de l'histoire complète ? Lire l'original sur Fox News ↗
Nous contacter FAQ